Stocks
Haemonetics Corporation (HAE) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 48.5% | 45.5% | 45.5% | 78.8% | 18.0% | ||||
| Changes by years, y/y, % | -40pp | -3pp | 0pp | -45pp | +21.3% | ||||
Haemonetics Corporation. R&D/CAPEX, %
Haemonetics Corporation. R&D/CAPEX, changes, pp
Haemonetics Corporation (HAE) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
| R&D/CAPEX, % | 130.9% | 51.4% | 59.5% | 6.25% | 144.5% | 18.0% | ||
| Changes by years, y/y, % | +107pp | +21pp | -16pp | -125pp | +13pp | |||
| Changes by quarters, q/q, % | 0pp | -80pp | +8pp | -53pp | +138pp | |||
